← All indications
Personality Disorders
A major deviation from normal patterns of behavior.
Subtype terms (10)
More specific conditions that are subtypes of Personality Disorders in the MeSH hierarchy.
- Antisocial Personality Disorder
7 drugs (6 approved, 1 experimental)
- Borderline Personality Disorder
36 drugs (29 approved, 7 experimental)
- Compulsive Personality Disorder
- Dependent Personality Disorder
- Histrionic Personality Disorder
- Narcissistic Personality Disorder
- Paranoid Personality Disorder
- Passive-Aggressive Personality Disorder
- Schizoid Personality Disorder
- Schizotypal Personality Disorder
5 drugs (4 approved, 1 experimental)
Drugs by status
Organizations
Organization Involved with Phase 4 Indications (11)
Organization Involved with Phase 3 Indications (11)
Organization Involved with Phase 2 Indications (22)
- Pfizer
- Hannover Clinical Trial Center GmbH
- Boehringer Ingelheim
- Columbia Northwest Pharmaceuticals
- Temple University
- Gottfried Wilhelm Leibniz Universität Hannover
- Indiana University
- Monash University
- New York University
- Northwestern University
- Ohio State University
- University of Chicago
- The Alfred Hospital
- University of Freiburg
- University of Barcelona
- Northwest Clinical Research Center
- Artemis Institute for Clinical Research
- National Center for Advancing Translational Science (NCATS)
- Brain & Behavior Research Foundation
- American Foundation for Suicide Prevention
- University of Southern Mississippi
- Government of Spain
Organization Involved with Other Experimental Indications (5)